U.S. flag

An official website of the United States government

GRCh37/hg19 10q26.2-26.3(chr10:130043370-135345340)x1 AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Apr 23, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002473957.1

Allele description [Variation Report for GRCh37/hg19 10q26.2-26.3(chr10:130043370-135345340)x1]

GRCh37/hg19 10q26.2-26.3(chr10:130043370-135345340)x1

Genes:
  • ADAM8:ADAM metallopeptidase domain 8 [Gene - OMIM - HGNC]
  • BNIP3:BCL2 interacting protein 3 [Gene - OMIM - HGNC]
  • EBF3:EBF transcription factor 3 [Gene - OMIM - HGNC]
  • JAKMIP3:Janus kinase and microtubule interacting protein 3 [Gene - OMIM - HGNC]
  • NKX6-2:NK6 homeobox 2 [Gene - OMIM - HGNC]
  • MGMT:O-6-methylguanine-DNA methyltransferase [Gene - OMIM - HGNC]
  • PWWP2B:PWWP domain containing 2B [Gene - HGNC]
  • TCERG1L-AS1:TCERG1L antisense RNA 1 [Gene - HGNC]
  • VENTX:VENT homeobox [Gene - OMIM - HGNC]
  • ADGRA1:adhesion G protein-coupled receptor A1 [Gene - OMIM - HGNC]
  • CALY:calcyon neuron specific vesicular protein [Gene - OMIM - HGNC]
  • CFAP46:cilia and flagella associated protein 46 [Gene - OMIM - HGNC]
  • CYP2E1:cytochrome P450 family 2 subfamily E member 1 [Gene - OMIM - HGNC]
  • DPYSL4:dihydropyrimidinase like 4 [Gene - OMIM - HGNC]
  • ECHS1:enoyl-CoA hydratase, short chain 1 [Gene - OMIM - HGNC]
  • FUOM:fucose mutarotase [Gene - OMIM - HGNC]
  • GLRX3:glutaredoxin 3 [Gene - OMIM - HGNC]
  • INPP5A:inositol polyphosphate-5-phosphatase A [Gene - OMIM - HGNC]
  • KNDC1:kinase non-catalytic C-lobe domain containing 1 [Gene - OMIM - HGNC]
  • LRRC27:leucine rich repeat containing 27 [Gene - HGNC]
  • LINC01166:long intergenic non-protein coding RNA 1166 [Gene - HGNC]
  • LINC02870:long intergenic non-protein coding RNA 2870 [Gene - HGNC]
  • MTG1:mitochondrial ribosome associated GTPase 1 [Gene - HGNC]
  • PAOX:polyamine oxidase [Gene - OMIM - HGNC]
  • PRAP1:proline rich acidic protein 1 [Gene - OMIM - HGNC]
  • PPP2R2D:protein phosphatase 2 regulatory subunit Bdelta [Gene - OMIM - HGNC]
  • STK32C:serine/threonine kinase 32C [Gene - HGNC]
  • SPRN:shadow of prion protein [Gene - OMIM - HGNC]
  • TCERG1L:transcription elongation regulator 1 like [Gene - HGNC]
  • TUBGCP2:tubulin gamma complex associated protein 2 [Gene - OMIM - HGNC]
  • UTF1:undifferentiated embryonic cell transcription factor 1 [Gene - OMIM - HGNC]
  • ZNF511:zinc finger protein 511 [Gene - HGNC]
Variant type:
copy number loss
Cytogenetic location:
10q26.2-26.3
Genomic location:
Chr10: 130043370 - 135345340 (on Assembly GRCh37)
Preferred name:
GRCh37/hg19 10q26.2-26.3(chr10:130043370-135345340)x1
HGVS:

    Condition(s)

    Synonyms:
    none provided
    Identifiers:
    MedGen: CN517202

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...

    Assertion and evidence details

    Submission AccessionSubmitterReview Status
    (Assertion method)
    Clinical Significance
    (Last evaluated)
    OriginMethodCitations
    SCV002773823Quest Diagnostics Nichols Institute San Juan Capistrano
    criteria provided, single submitter

    (ACMG/ClinGen CNV Guidelines, 2019)
    Pathogenic
    (Apr 23, 2022)
    unknownclinical testing

    PubMed (1)
    [See all records that cite this PMID]

    Summary from all submissions

    EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
    not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

    Citations

    PubMed

    Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen).

    Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, Raca G, Ritter DI, South ST, Thorland EC, Pineda-Alvarez D, Aradhya S, Martin CL.

    Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6. Erratum in: Genet Med. 2021 Nov;23(11):2230. doi: 10.1038/s41436-021-01150-9.

    PubMed [citation]
    PMID:
    31690835
    PMCID:
    PMC7313390

    Details of each submission

    From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV002773823.1

    #EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
    1not providednot providednot providednot providedclinical testing PubMed (1)

    Description

    The copy number loss of 10q26.2q26.3 involves multiple protein-coding genes, including EBF3 (OMIM 607407). Deletions within 10q26.2q26.3 are associated with chromosome 10q26 deletion syndrome (OMIM 609625). The common clinical features include developmental delays (DD), distinctive facial dysmorphism, cardiac abnormalities, and urogenital anomalies (Lin 2016; Yatsenko 2009). A 500 kb minimal overlapping region of 10q26 deletion syndrome has been proposed which includes DOCK1, INSYN2 and NPS, which are not included in the current interval (Cherik 2021; Faria 2016). However, several reports have proposed other minimum critical regions for each phenotype, with the current interval being likely associated with craniofacial anomalies, DD, intellectual disability (ID) and possibly cardiac malformations (Ignatius 2020; Lacaria 2017; Lin 2016; Lopes 2017; Nishi 2021; Plaisancie 2014). Additionally, heterozygous sequence variants of EBF3 are associated with hypotonia, ataxia, and delayed development syndrome (HADDS; 617330), and there are multiple genes in this copy number loss that are associated with autosomal recessive disorders: NKX6-2 (OMIM 605955), TUBGCP2 (OMIM 617817), and ECHS1 (OMIM 602292). Even though copy number losses of this specific interval have not yet been associated with a clinical phenotype, there are no similar copy number losses of this region in the general populations of the Database of Genomic Variants. Thus, based on current medical literature and gene content, this copy number variant (CNV) is interpreted as pathogenic. Unique Rare Chromosome Disorders website has a booklet on 10q25 and 10q26 deletions which may be helpful for patient and family education (https://rarechromo.org/media/information/Chromosome%2010/10q25%20and% 2010q26%20deletions%20FTNW.pdf). References: Cherik et al., Eur J Med Genet. 2021 Jul 9;64(9):104287. PMID: 34252586. Faria et al., Am J Med Genet A. 2016 Feb;170A(2):403-9. PMID: 26566760. Ignatius et al., Neurol Genet. 2020 Jun 5;6(4):e444. PMID: 32637629. Lacaria et al., Am J Med Genet A. 2017 Jun;173(6):1611-1619. PMID: 28432728. Lin et al., Mol Med Rep. 2016 Dec;14(6):5134-5140. PMID: 27779662. Lopes et al., Front Genet. 2017 Oct 9;8:143. PMID: 29062322. Nishi et al., Am J Med Genet A. 2021 Oct;185(10):2913-2921. PMID: 34050706. Plaisancie et al., Eur J Med Genet. 2014 Jan;57(1):47-53. PMID: 24275544. Yatsenko et al., Clin Genet. 2009 Jul;76(1):54-62. PMID: 19558528.

    #SampleMethodObservation
    OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
    1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

    Last Updated: Dec 31, 2022